21 May 2013
Keywords: daiichi, sankyo, takes, japanese, rights, cs-8958, lani
Article | 02 April 2009
Australia's Biota Holdings says that Daiichi Sankyo, the co-owner of the long-acting neuraminidase inhibitor CS-8958, has signed a contract
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
31 March 2009
30 March 2009
20 May 2013
© 2013 thepharmaletter.com